Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions
About this study
1. Breast cancer patients and age-matched controls are first invited to answer questions on HRQoL. 2. Among responding breast cancer patients, a subset are invited in a randomized clinical trial with two digital interventions for cancer stress management, cognitive based stress management (CBSM) and mindfulness based intervention (MBI), as well as a control group. 3. The goal is to determine whether digital CBSM or MBI can effectively reduce stress levels as compared to a control group. Second, whether these interventions can improve HRQoL (or avoid onset of HRQoL problems) for patients with breast cancer, compared to a control group.
- Condition
- Breast Cancer Patients, Health, Subjective
- Tested
- Stressproffen cognitive based stress management, Stressproffen mindfulness based intervention, Control
- Sponsor
- Norwegian Institute of Public Health
Who can join
- Age
- 20 to 69 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
Inclusion 10
- Minimum age: 20 years
- Maximum age: 69 years
- Eligible sex: Female
- Study condition: Breast Cancer Patients, Health, Subjective
- first occurrence breast cancer diagnosed from Jan 1, 2020
- non-metastatic cancer stage 0-III
- Invasive tumors must be:
- HER2 positive (regardless of ER, PR) or
- ER negative
- (may later include other ER+ if not conflict with recruitment for EMIT/OPTIMA)
Where
1 site, 1 recruiting
Cancer Registry of Norway
Oslo, Norway
Contact
-
Giske Ursin, MD, PhD
+4722451300 giske.ursin@kreftregisteret.no
-
Ine M Larsson
+4722928985 ine.marie.larsson@kreftregisteret.no
Potential match only. Final eligibility is determined by the study team.